-
Validation of Lysosomal Enzymes Assay in CSF - One-year Extension of the RRIA: CSF Lysosomal Hydrolases' Activity as Possible Marker of Parkinson's Disease
… This grant builds upon the research from a prior grant: CSF Lysosomal Hydrolases' … analysis of blood or cerebrospinal fluid (CSF) for clinical diagnosis of PD. Recent studies have supported clinical, … is necessary for their subsequent use in clinical practice. Early and accurate clinical diagnosis is mandatory in order …
-
Validation of the Movement Disorders Society’s Clinical Criteria of Parkinson’s Disease
… Study Rationale: Diagnosis of Parkinson’s disease (PD) and other causes of … is not always an easy task for physicians. An accurate diagnosis, however, is an essential aspect of care for people with Parkinson’s and of research trials, where the inclusion of incorrectly …
-
Clinical Development of the PET Tracer Candidate MODAG-009 for quantitative Detection of Alpha-synuclein Pathology in Parkinson’s Disease
… the brain are urgently needed. Such tests could aid disease diagnosis and help to measure the effects of experimental … volunteers, and between PD and MSA patients. Impact on Diagnosis/Treatment of Parkinson’s disease: MODAG-009 could … with Parkinson's disease or MSA. This would enable the early and differential diagnosis of these diseases, as well …
-
Comparative Characterization of Alpha-synuclein Species and Identification of Antibodies that Detect and Capture Alpha-synuclein
… disease (PD) is crucial for diagnosing the disease early, monitoring disease progression, designing clinical … strategies. Alpha-synuclein is a protein that aggregates into clumps in the cells of PD patients. The primary … of mass-spectrometry and proteomics-based approaches, researchers plan to assess the chemical integrity of …
-
Parkinson’s Clinical Cohorts Collaborative (PC3)
… they cover the earliest stages of disease, even before diagnosis, right up to the most advanced stages. Moreover, … certificates. The resource will be made available to the research community and will enable us to answer pressing … First, we will bring all the data from these studies into one place and "harmonise" it for analysis. This will …
-
Detecting Colonic Alpha-synuclein with an Antibody Specific for Disease-associated Forms as a Biomarker of Parkinson’s Disease
… of control cases with a negative signal). Impact on Diagnosis/Treatment of Parkinson’s Disease: Currently there … and, finally, could potentially identify people in very early stages of disease when new treatments may be most … PD to determine if this can identify people in very early stages of disease. As many countries have screening …